2024-09-06 - Analysis Report
## HCA Stock Analysis Report

**Company:** HCA Healthcare, Inc. (HCA) is one of the largest healthcare providers in the United States, operating hospitals and other healthcare facilities in various states.

**1. Performance vs. S&P 500:**

* **HCA Cumulative Return:** 168.54%
* **S&P 500 (VOO) Cumulative Return:** 84.86%
* **Difference:** 83.68%
* **Relative Divergence:** 100.0% (Currently at the highest point compared to historical data)

HCA has significantly outperformed the S&P 500, showing a substantial 83.68% difference in cumulative returns. Its performance is at the highest point compared to historical data, indicating a strong performance against the broader market.

**2. Recent Price Movements:**

* **Closing Price:** $394.3
* **5-Day Moving Average:** $393.74
* **20-Day Moving Average:** $378.34
* **60-Day Moving Average:** $350.02

HCA's recent price action suggests positive momentum. The price is above all three moving averages, indicating an upward trend. The 5-day moving average is close to the closing price, implying potential continuation of the upward trend in the short term.

**3. Technical Indicators:**

* **RSI:** 93.13 (Overbought)
* **PPO:** 0.07 (Positive)
* **Delta_Previous_Relative_Divergence:** 1.17 (Positive, indicating short-term upward trend)
* **Expected Return:** 0.0% (Current maximum estimated 5-year return on invested capital)

The RSI indicates the stock is currently overbought, suggesting potential for a near-term correction. The positive PPO and the upward trend indicated by the Delta_Previous_Relative_Divergence support the idea of continued upward movement. However, the overbought condition warrants cautious observation. The expected return is currently 0%, potentially due to the overbought condition and the need for a potential pullback.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | $17.49 B |
| 2024-05-02 | 6.01 | $17.34 B |
| 2023-10-26 | 3.98 | $16.21 B |
| 2023-08-02 | 4.35 | $15.86 B |
| 2024-07-29 | 4.35 | $15.86 B |

HCA has been consistently exceeding revenue and earnings expectations. The latest quarter showed impressive results with an EPS of 5.6, exceeding analyst expectations. This strong performance highlights the company's robust financial position and potential for continued growth.

**5. Conclusion:**

HCA's stock has significantly outperformed the market, showing a strong upward trend and impressive recent earnings. However, the overbought condition indicated by the RSI suggests a potential correction in the near future. The company's financial performance remains strong, and the expected return is currently 0%. Investors should closely monitor the stock's price action and potential for a correction, while remaining aware of the long-term growth potential of HCA. 
